Yabao Pharmaceutical (600351.SH) signed a technology transfer agreement for a new Chinese medicine project.
Choicetou Finance APP News, Yabao Pharmaceuticals (600351.SH) announced that on August 4, 2025, the company signed a technical transfer agreement for a new traditional Chinese medicine project with Shanxi Provincial Traditional Chinese Medicine Research Institute (referred to as "Shanxi Provincial Chinese Medicine Hospital"). The company acquired the clinical trial batch approval, patent rights, and related technical information of the traditional Chinese medicine Class 1 new drug "Chaiqin Ningshen Granules" owned by Shanxi Provincial Chinese Medicine Hospital for RMB 22 million.
Latest